Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIndivior Regulatory News (INDV)

Share Price Information for Indivior (INDV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,240.00
Bid: 1,240.00
Ask: 1,245.00
Change: -37.00 (-2.90%)
Spread: 5.00 (0.403%)
Open: 1,277.00
High: 1,284.00
Low: 1,240.00
Prev. Close: 1,277.00
INDV Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Holding(s) in Company

2 Sep 2022 09:24

RNS Number : 0926Y
Indivior PLC
02 September 2022
 

TR-1: Standard form for notification of major holdings

1. Issuer Details

ISIN

GB00BRS65X63

Issuer Name

INDIVIOR PLC

UK or Non-UK Issuer

UK

2. Reason for Notification

Other

Comments

Intra-group business and assets transfer from Ignis Investment Services Limited to abrdn Investment Management Limited

3. Details of person subject to the notification obligation

Name

Aggregate of abrdn plc affiliated investment management entities with delegated voting rights on behalf of multiple managed portfolios

City of registered office (if applicable)

Edinburgh

Country of registered office (if applicable)

United Kingdom

4. Details of the shareholder

Full name of shareholder(s) if different from the person(s) subject to the notification obligation, above

 

City of registered office (if applicable)

 

Country of registered office (if applicable)

 

5. Date on which the threshold was crossed or reached

31-Aug-2022

6. Date on which Issuer notified

02-Sep-2022

7. Total positions of person(s) subject to the notification obligation

% of voting rights attached to shares (total of 8.A)

% of voting rights through financial instruments (total of 8.B 1 + 8.B 2)

Total of both in % (8.A + 8.B)

Total number of voting rights held in issuer

Resulting situation on the date on which threshold was crossed or reached

6.365823

0.000000

6.365823

44,056,289

Position of previous notification (if applicable)

9.073008

0.000000

9.073008

8. Notified details of the resulting situation on the date on which the threshold was crossed or reached

8A. Voting rights attached to shares

Class/Type of shares ISIN code(if possible)

Number of direct voting rights (DTR5.1)

Number of indirect voting rights (DTR5.2.1)

% of direct voting rights (DTR5.1)

% of indirect voting rights (DTR5.2.1)

GB00BRS65X63

44,056,289

6.365823

Sub Total 8.A

44,056,289

6.365823

8B1. Financial Instruments according to (DTR5.3.1R.(1) (a))

Type of financial instrument

Expiration date

Exercise/conversion period

Number of voting rights that may be acquired if the instrument is exercised/converted

% of voting rights

 

Sub Total 8.B1

8B2. Financial Instruments with similar economic effect according to (DTR5.3.1R.(1) (b))

Type of financial instrument

Expiration date

Exercise/conversion period

Physical or cash settlement

Number of voting rights

% of voting rights

 

Sub Total 8.B2

9. Information in relation to the person subject to the notification obligation

2. Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entities (please add additional rows as necessary)

Ultimate controlling person

Name of controlled undertaking

% of voting rights if it equals or is higher than the notifiable threshold

% of voting rights through financial instruments if it equals or is higher than the notifiable threshold

Total of both if it equals or is higher than the notifiable threshold

abrdn plc

abrdn plc

abrdn Investments (Holdings) Limited

abrdn plc

abrdn Investment Management Limited

6.126837

0.000000

6.126837

abrdn plc

abrdn plc

Aberdeen Asset Management PLC

abrdn plc

Aberdeen Asset Managers Limited

abrdn plc

abrdn plc

abrdn Investments (Holdings) Limited

abrdn plc

abrdn Capital Limited

10. In case of proxy voting

Name of the proxy holder

 

The number and % of voting rights held

 

The date until which the voting rights will be held

 

11. Additional Information

In reference to Section 9, the shares detailed are managed by the named discretionary investment management entity within multiple portfolios on behalf of underlying clients, based on investment management agreements whereby the client has delegated the exercise of the voting power to the referenced investment manager.This disclosure reflects the fact that the voting rights held indirectly by the underlying investment management entity abrdn Investment Management Limited ("aIML") increased above the 5% notifiable threshold due to an internal corporate restructure on 31 August 2022. aIML now holds the delegated voting rights to 6.126837% of the shares in Indivior PLC.

12. Date of Completion

02-Sep-2022

13. Place Of Completion

Aberdeen, United Kingdom

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
HOLSSDSAEEESEEU
Date   Source Headline
1st Jul 20197:00 amRNSTotal Voting Rights
25th Jun 20197:00 amRNSHolding(s) in Company
18th Jun 201912:31 pmRNSIndivior Presents RECOVER Study Data at CPDD 2019
14th Jun 20198:47 amRNSHolding(s) in Company
29th May 20197:00 amRNSHolding(s) in Company
24th May 20199:04 amRNSHolding(s) in Company
17th May 20199:55 amRNSHolding(s) in Company
16th May 20197:00 amRNSIndivior to Participate in Conference
15th May 20197:00 amRNSDirector/PDMR Shareholding
13th May 20193:43 pmRNSDirector/PDMR Shareholding
13th May 20197:00 amRNSHolding(s) in Company
13th May 20197:00 amRNSHolding(s) in Company
9th May 201911:30 amRNSLicensing of PERSERIS in Canada
9th May 201910:29 amRNSBlock listing Interim Review
8th May 20191:54 pmRNSResult of AGM
3rd May 20197:00 amRNSHolding(s) in Company
2nd May 201912:00 pmRNS1st Quarter Results
2nd May 20197:00 amRNSHolding(s) in Company
1st May 20199:56 amRNSHolding(s) in Company
29th Apr 20194:16 pmRNSHolding(s) in Company
29th Apr 20191:35 pmRNSHolding(s) in Company
29th Apr 20191:25 pmRNSHolding(s) in Company
29th Apr 20191:16 pmRNSHolding(s) in Company
18th Apr 20199:24 amRNSChange of Registered Office
17th Apr 20193:26 pmRNSHolding(s) in Company
10th Apr 20197:00 amRNSStatement of Indivior on Grand Jury Indictment
9th Apr 20197:00 amRNSHolding(s) in Company
8th Apr 20199:18 amRNSIndivior publishes new research on opioid use disorder
8th Apr 20197:00 amRNSIndivior Presents RECOVER Study Data at ASAM 2019
5th Apr 20191:30 pmRNSIndivior Announces New Data at ASAM Conference
4th Apr 20197:00 amRNSNotice of Results
3rd Apr 201910:38 amRNSHolding(s) in Company
18th Mar 20194:27 pmRNSHolding(s) in Company
15th Mar 20195:00 pmRNSHolding(s) in Company
14th Mar 20192:00 pmRNSAnnual Financial Report
8th Mar 20192:30 pmRNSDirectorate Change
7th Mar 20192:00 pmRNSPatient-centered Outcomes Published
6th Mar 201910:37 amRNSDirector/PDMR Shareholding
4th Mar 20194:54 pmRNSHolding(s) in Company
1st Mar 20197:00 amRNSTotal Voting Rights
28th Feb 20193:31 pmRNSHolding(s) in Company
27th Feb 20191:00 pmRNSIndivior Launches PERSERIS (risperidone)
26th Feb 20193:10 pmRNSDirector Declaration
20th Feb 20199:06 amRNSHolding(s) in Company
20th Feb 20197:00 amRNSIndivior Launches SUBOXONE Film Authorized Generic
19th Feb 20197:00 amRNSThe Lancet Publishes Phase 3 Results of SUBLOCADET
14th Feb 20197:00 amRNSFinal Results
12th Feb 20197:00 amRNSFederal Court Denies Motion to Stay
5th Feb 20197:00 amRNSIndivior Responds to CAFC Rehearing Decision
4th Feb 20197:05 amRNSIndivior Enters into Agreement with Alvogen

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.